Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BMS-986408 |
Trade Name | |
Synonyms | BMS 986408|BMS986408 |
Drug Descriptions |
BMS-986408 inhibits DGKalpha and DGKzeta, which may increase TCR signaling and enhance antitumor immune response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | 2618418-12-3 |
NCIT ID | C211877 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BMS-986408 | BMS-986408 | 0 | 1 |
BMS-986408 + Ipilimumab + Nivolumab | BMS-986408 Ipilimumab Nivolumab | 0 | 1 |
BMS-986408 + Nivolumab | BMS-986408 Nivolumab | 0 | 1 |